| |
| |
|
| Insider
Information: |
Lloyd George W. |
| Relationship: |
EVP, Investments & CLO |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,000 |
|
|
Indirect Shares
|
993,831 |
|
|
| Direct
Value |
$85,230 |
|
|
|
Indirect Value
|
$28,234,739 |
|
|
| Total
Shares |
996,831 |
|
|
| Total
Value |
$28,319,969 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Royalty Pharma Plc |
RPRX |
EVP, Investments & CLO |
2023-11-13 |
3,000 |
2023-11-13 |
993,831 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
150,000 |
220,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-06-06 |
4 |
S |
$33.82 |
$2,674,796 |
I/I |
(79,099) |
30,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-06-05 |
4 |
S |
$33.54 |
$644,446 |
I/I |
(19,215) |
109,099 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-06-02 |
4 |
S |
$33.54 |
$3,159,345 |
I/I |
(93,907) |
128,314 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-03-29 |
4 |
S |
$37.03 |
$473,165 |
I/I |
(12,779) |
212,221 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-03-28 |
4 |
S |
$37.06 |
$3,706,130 |
I/I |
(100,000) |
225,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-02-23 |
4 |
S |
$37.27 |
$931,658 |
I/I |
(25,000) |
325,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2022-11-22 |
4 |
S |
$43.14 |
$706,848 |
I/I |
(16,369) |
350,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2022-11-21 |
4 |
S |
$43.11 |
$1,018,719 |
I/I |
(23,631) |
351,900 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2022-11-10 |
4 |
AS |
$43.85 |
$2,192,613 |
I/I |
(50,000) |
355,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-08-10 |
4 |
S |
$43.93 |
$395,108 |
I/I |
(8,995) |
201,114 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-08-09 |
4 |
S |
$43.92 |
$520,801 |
I/I |
(11,859) |
210,109 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-28 |
4 |
S |
$43.97 |
$177,893 |
I/I |
(4,046) |
221,968 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-27 |
4 |
S |
$43.76 |
$1,098,445 |
I/I |
(25,100) |
226,014 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-26 |
4 |
S |
$43.03 |
$833,047 |
I/I |
(19,329) |
226,114 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-25 |
4 |
S |
$42.90 |
$1,316,708 |
I/I |
(30,671) |
228,886 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-05-27 |
4 |
S |
$40.77 |
$569,754 |
I/I |
(13,974) |
430,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-05-26 |
4 |
S |
$40.21 |
$3,459,338 |
I/I |
(86,026) |
443,974 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-05-23 |
4 |
S |
$40.27 |
$4,026,770 |
I/I |
(100,000) |
530,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-11-17 |
4 |
S |
$42.39 |
$3,566,832 |
I/I |
(84,148) |
630,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-11-16 |
4 |
S |
$42.12 |
$7,029,862 |
I/I |
(165,852) |
714,148 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-26 |
4 |
S |
$39.76 |
$531,532 |
I/I |
(13,362) |
780,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-13 |
4 |
S |
$42.01 |
$968,252 |
I/I |
(23,049) |
788,449 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-12 |
4 |
S |
$42.04 |
$4,204 |
I/I |
(100) |
806,430 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-08 |
4 |
S |
$42.05 |
$2,062,789 |
I/I |
(49,059) |
806,530 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
